The good news coming from the Supreme Court was that in the United States, genes could not be patented…This had two enormous practical implications: one is it meant that there could now be competition to develop better, more accurate, less expensive tests for the gene…And the second is that poor women would have a more equal chance to live — in this case, to conquer breast cancer…Myriad’s effort to patent human DNA was one of the worst manifestations of the inequality in access to health…[Refers to Ambry Genetics, Gene by Gene, Myriad Genetics]